Cite
MLA Citation
Eric F Morand et al.. “Attainment of treat-to-target endpoints in SLE patients with high disease activity in the atacicept phase 2b ADDRESS II study.” Rheumatology, vol. 59, 2020, pp. 2930–2938. http://access.bl.uk/ark:/81055/vdc_100116968588.0x000023